Atlas Trials

A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

Clinical trial NCT05293938 · WITHDRAWN

Trial details

NCT number
NCT05293938
Sponsor
Intercept Pharmaceuticals
Status
WITHDRAWN
Study type
OBSERVATIONAL
Primary Biliary Cholangitis
Start date
2022-03-28
Primary completion
2023-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.